MiBiome™ Advanced Topical Suspension

Innovative, all-natural skin soothing topical suspension to improve red, dry and scaly skin, often associated with Psoriasis and Eczema

Shop now

A Game-Changer in Skin Care

MiBiome™ is a novel, patented skincare product, formulated with SEKDA™ Probiotic Complex for the topical treatment of Psoriasis, with proven effectiveness in treating Atopic Dermatitis (Eczema), Rosacea, Tinea Versicolor and other chronic inflammatory skin diseases

  • All-Natural

    MiBiome™ Advanced Topical Suspension is an innovative all-natural product, formulated with SEKDA™ Probiotic Complex which has a positive impact on the dermal microbiome

    • No side effects
    • All natural ingredients
    • Steroid free
    • SLS and SLES free
    • Dye free
    • Fragrance free
    • Dairy, soy, and gluten free
  • Research

    The microbiome of unhealthy skin differs from that of healthy skin. ClearSkin scientists have developed an innovative suspension formula enriched with a unique SEKDA™ Probiotic Complex. MiBiome™ Advanced Topical Suspension acts as a skin probiotic, rebalancing the dermal microbiome.

    What is a Microbiome?
  • Composition

    MiBiome™ Advanced Topical Suspension is an innovative, all-natural product formulated with a probiotic complex to soothe and rebalance the ecosystem of the skin.

    Each ingredient was chosen for its known beneficial dermal characteristics to leave your irritated skin soothed, softer more nourished, and more pleasant to the touch.

  • Proven Results

    Clinical study shows improvement in Psoriatic cases in 2-3 weeks with patients staying clear of symptoms for more than two years.

    In a clinical study performed on mild to moderate psoriasis patients results showed that MiBiome was effective in over 80% of patients when applied twice daily for at least 60 days.

  • Cosmetic Regulation

    • Dermatologically tested
    • Cosmetic European safety report
    • Approved in EU – (CPNP Notification)
    • Approved by MoH of Israel
    • Marketed in EU, Israel, UK, Philippines, USA for human use as a cosmetic product
    • Health Canada Notification